Wiener Gesundheitsverbund, Klinik Favoriten
Vienna 1100
1 studies enrolling now · 2 studies all time
What they study most
Carcinoma, Hepatocellular, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension
Studies at this site
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
- A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma — Completed